|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase lll trial of maintenance bevacizumab with or without pemetrexed after first- line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non - small - cell lung cancer显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oncol2013，31，24： | 1 |
| 2 | Randomizedphase K trial of maintenance bevacizumab with or withoutpemetrexed after first-line induction with bevacizumab,cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer : AVAPERL ( M022089 ) 显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | JClin Oncol2013，31，24： | 1 |
| 3 | Randomized phase II1 trial of maintenance bevacizumab with or without pemetrexed after first- line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089)显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oncol2013，31，24： | 1 |
| 4 | Smoking,chronic obstructive pulmonary disease and lung cancer显示文摘 | Andreas S Herth FJ Rittmeyer A | 2007 | Pneumologie2007，61，9： | 1 |
| 5 | Health-Related Quali- ty of Life in Patients with Advanced Nonsquamous Non-Small-CeU Lung Cancer Receiving Bevaeizumab or Bevacizumab-Plus-Peme- trexed Maintenance Therapy in AVAPERL (MO22089) 显示文摘 | Rittmeyer A Gorbunova V V-lkstriom A | 2013 | J Thomc Oncol2013，8，11： | 1 |
| 6 | Health - related qual- ity of life in patients with advanced nonsquamous non - small - cell lung cancer receiving bevacizumab or bevacizumab - plus - peme- trexed maintenance therapy in AVAPERL (MO22089) 显示文摘 | Rittmeyer A Gorbunova V Vikstrom A | 2013 | J Thorac Oncol2013，8，11： | 1 |
| 7 | Randomized phaseⅢtrial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer:AVAPERL(MO22089)显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oncol2013，31，24： | 1 |
| 8 | Randomized phase Ⅲ trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small cell lung cancer: AVAPERL 显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oncol2013，31，24： | 1 |
| 9 | Randomized phase Ⅲ trial of maintenance bevacizumab w'ith or without pemetrexed after first - line induction with bevaeizumab, cisplatin, and pemetrexed in advanced nonsquamous non - small - cell lung cancer 显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oneol2013，31，24： | 1 |
| 10 | Randomized phase Ⅲ trial of maintenance bevacizumab with or with- out pemetrexed after first-line induction with bevacizum-ab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer : AVAPERL (MO22089) 显示文摘 | Barlesi F Scherpereel A Rittmeyer A | 2013 | J Clin Oncol2013，31，24： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员